title: Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students.
abstract: BACKGROUND
  Previous findings regarding risk factors for human papillomavirus (HPV) persistence, other than viral determinants, identified from prospective cohort studies have been inconsistent in part because study designs have differed with respect to differing HPV detection methods and varying lengths of follow-up time. Therefore, the objectives of this study were to continue the search for epidemiologic risk factors of persistent cervical HPV infections and determine what behaviors differed between those women with transient HPV infections and those women who cannot clear their type-specific HPV infections.
  
  
  METHODS
  Female university students (n = 621) in Montreal were followed for 24 months at 6-month intervals. At each visit, a cervical cell specimen was collected. HPV DNA was detected using the MY09/MY11 PCR protocol and 27 HPV genotypes were identified by the line blot assay (Roche Molecular Systems, Inc., Alameda, CA). Proportional hazards regression was used to estimate the crude and adjusted hazard ratios of clearing a type-specific high-risk (n = 222) or low-risk (n = 105) HPV infection over time according to specific baseline and time-dependent covariates.
  
  
  RESULTS
  Daily consumption of vegetables seemed to increase the rate of HPV clearance independent of type. The use of tampons was associated with a reduced rate of high-risk HPV clearance, whereas regular condom use was associated with an increased rate of low-risk HPV clearance only.
  
  
  CONCLUSIONS
  Some proactive measures can be taken to increase the rate of HPV clearance, and there may be some differences between the sets of predictors of low-risk and high-risk HPV clearance.
authors.affiliation: Department of Oncology, McGill University, 546 Pine Avenue West, Montreal, Quebec, Canada H2W 1S6.
authors.forename: Harriet
authors.initials: H
authors.lastname: Richardson
authors.forename: Michal
authors.initials: M
authors.lastname: Abrahamowicz
authors.forename: Pierre-Paul
authors.initials: PP
authors.lastname: Tellier
authors.forename: Gail
authors.initials: G
authors.lastname: Kelsall
authors.forename: Roxane
authors.initials: R
authors.lastname: du Berger
authors.forename: Alex
authors.initials: A
authors.lastname: Ferenczy
authors.forename: François
authors.initials: F
authors.lastname: Coutlée
authors.forename: Eduardo L
authors.initials: EL
authors.lastname: Franco
mesh_terms: D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D017280:Condoms; D005260:Female; D005838:Genotype; D006801:Humans; D027383:Papillomaviridae / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000235:genetics / Q000517:prevention & control; D016133:Polymerase Chain Reaction; D016016:Proportional Hazards Models; D011792:Quebec / Q000453:epidemiology; D018570:Risk Assessment; D012307:Risk Factors; D012309:Risk-Taking; D013334:Students; D011795:Surveys and Questionnaires; D013630:Tampons, Surgical / Q000009:adverse effects; D014495:Universities; D014626:Vaginal Smears; D016387:Women's Health